Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Titel:
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Auteur:
Pishvaian, Michael Morse, Michael A. McDevitt, Jennifer Norton, Jonathan D. Ren, Song Robbie, Gabriel J. Ryan, Patricia C. Soukharev, Serguei Bao, Haifeng Denlinger, Crystal S.